Why the study?
Recommendations for younger and masters athletes have been extrapolated to aging athletes, but specific guidelines, treatment algorithms, and considerations for this population remain scarce.
This review highlights the unique cardiovascular and muscular physiology of aging athletes (≥60 years) and discusses prevention and treatment strategies for this growing population.
No takes yet. Share an insight, caveat, or question.
Lack of aging-athlete guidelines warrants caution extrapolating from younger cohorts; leaves optimal risk-benefit strategies open for dedicated study.
Catapano et al. (2022) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: